Michigan State University scientists have linked a common food preservative to an altered immune response that possibly hinders flu vaccines.
The study conducted in mice, presented at the 2019 Experimental Biology meeting in Orlando, Fla., April 7 at 9 a.m., offers up a new potential factor in vaccine effectiveness.
Tert-butylhydroquinone, or tBHQ, can be found in several food products including cooking oils, frozen meats (especially fish) and processed foods such as chips and crackers. Products don't always have to include it on ingredient lists.
"If you get a vaccine, but part of the immune system doesn't learn to recognize and fight off virus-infected cells, then this can cause the vaccine to be less effective," said Robert Freeborn, a fourth-year doctoral student who led the study with Cheryl Rockwell, an associate professor in pharmacology and toxicology. "We determined that when tBHQ was introduced through the diet, it affected certain cells that are important in carrying out an appropriate immune response to the flu."
Using various flu strains including H1N1 and H3N2, Freeborn and Rockwell focused on CD4 and CD8 T cells and incorporated tBHQ into the food of mice in an amount comparable to human consumption.
"CD4 T cells are like movie directors that tell everyone else what to do," Freeborn said. "The CD8 T cells are the actors that do what the director wants."
The researchers looked at several response factors including whether the T cells showed up, were able to do the right job and ultimately, recognize and remember the invading virus.
"Overall, we saw a reduced number of CD8 T cells in the lung and a reduction in the number of CD4 and CD8 T cells that could identify the flu virus in the mice that were exposed to tBHQ," Freeborn said. "These mice also had widespread inflammation and mucus production in their lungs."
TBHQ also slowed down the initial activation of T cells, reducing their ability to fight off an infection sooner. This allowed the virus to run rampant in the mice until the cells fully activated.
A second phase of the study showed the additive hindered the immune system's ability to remember how to respond to the flu virus, particularly when another strain was introduced at another time. This resulted in a longer recovery and additional weight loss in the mice.
"It's important for the body to be able to recognize a virus and remember how to effectively fight it off," Freeborn said. "That's the whole point of vaccines, to spur this memory and produce immunity. TBHQ seems to impair this process."
The research was funded by the National Institutes of Health.
Source: Michigan State University
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.
Global Patients, Local Risks: Why Medical Tourism Demands Infection Preventionists’ Attention
June 16th 2025At APIC25, infection prevention leader Heather Stoltzfus, MPH, RN, CIC, will spotlight the growing risks and overlooked responsibilities associated with medical tourism. Her session urges infection preventionists to engage with a global health trend that directly impacts US care settings.